UNCY - Unicycive Therapeutics, Inc.
6.59
-0.240 -3.642%
Share volume: 692,030
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
-0.24
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-13-2024 | 05-14-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 9.204 M | 7.401 M | 6.251 M | 7.989 M | 7.342 M | |
| Selling general and admin | 2.391 M | 2.533 M | 3.206 M | 5.818 M | 4.378 M | |
| Research and development | 6.813 M | 4.868 M | 3.045 M | 2.171 M | 2.964 M | |
| Total expenses | 9.204 M | 7.401 M | 6.251 M | 7.989 M | 7.342 M | |
| -19.59% | -15.54% | 27.80% | -8.10% | |||
| Operating income | -9.204 M | -7.401 M | -6.251 M | -7.989 M | -7.342 M | |
| Ebit | -21.012 M | 9.409 M | -4.497 M | 359.000 K | -6.275 M | |
| Pretax income | -20.963 M | 9.855 M | -4.096 M | 570.000 K | -6.011 M | |
| -147.01% | -141.56% | -113.92% | -1,154.56% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -20.963 M | 9.855 M | -4.096 M | 570.000 K | -6.011 M | |
| 147.01% | -141.56% | 113.92% | -1,154.56% |